. 2008 Oct 28;10(10):247.

Table 5.

Patient-Reported Experiences With INSs in Surveys 1, 2, 3, 5[22–24,26]

Category	Experience	Respondents, %	Survey
Satisfaction^a	Very satisfied with INS treatment	35%	1
Satisfaction^a	Satisfied with INS treatment	62%	3
Reasons not to use	Believe INSs lose effectiveness if used too much	34-61% (France, Germany, Italy, Spain)	2
Most important benefit	Prevention of nasal congestion	38%	3
Survey 5^b
Most important ease-of-use attributes	Easy to use Easy to pump/press Easy to administer mist	All categories of patients chose these as the most important attributes

INSs = intranasal corticosteroids.

Of those dissatisfied with another current therapy, 28% said they would try INSs in the future.

Comprised preidentified mometasone furoate nasal spray users.